Cargando…

Comprehensive Analysis of a Cancer-Immunity Cycle–Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer

Immune checkpoint blockade (ICB) has been recognized as a promising immunotherapy for colorectal cancer (CRC); however, most patients have little or no clinical benefit. This study aimed to develop a novel cancer-immunity cycle–based signature to stratify prognosis of patients with CRC and predict e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hou, Yufang, Zhang, Rixin, Zong, Jinbao, Wang, Weiqi, Zhou, Mingxuan, Yan, Zheng, Li, Tiegang, Gan, Wenqiang, Lv, Silin, Zeng, Zifan, Yang, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193226/ https://www.ncbi.nlm.nih.gov/pubmed/35711437 http://dx.doi.org/10.3389/fimmu.2022.892512

Ejemplares similares

Developing an m5C regulator–mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer
por: Zhang, Rixin, et al.
Publicado: (2023)

Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients
por: Zhang, Fang, et al.
Publicado: (2023)

Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer
por: Zhou, Mingxuan, et al.
Publicado: (2022)

SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer
por: Li, Tiegang, et al.
Publicado: (2021)

Indoleamine 2, 3-Dioxygenase 1 and CD8 Expression Profiling Revealed an Immunological Subtype of Colon Cancer With a Poor Prognosis
por: Zhang, Rixin, et al.
Publicado: (2020)

Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy
por: Li, Tiegang, et al.
Publicado: (2022)

High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma
por: Hou, Yufang, et al.
Publicado: (2020)

Prognostic Values and Underlying Regulatory Network of Cohesin Subunits in Esophageal Carcinoma
por: Gan, Wenqiang, et al.
Publicado: (2022)

Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma
por: Hou, Yufang, et al.
Publicado: (2020)

A bioinformatics analysis on the potential role of ACE2 in cardiac impairment of patients with coronavirus disease 2019
por: Wang, Weiqi, et al.
Publicado: (2020)

Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis
por: Li, Xiushen, et al.
Publicado: (2023)

A combined aging and immune prognostic signature predict prognosis and responsiveness to immunotherapy in melanoma
por: Lv, Wenchang, et al.
Publicado: (2022)

Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer
por: Cui, Hanxiao, et al.
Publicado: (2023)

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy
por: Zhao, Qinfei, et al.
Publicado: (2022)

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
por: Zhang, Yichi, et al.
Publicado: (2022)

A WGCNA-based cancer-associated fibroblast risk signature in colorectal cancer for prognosis and immunotherapy response
por: Lv, Yiming, et al.
Publicado: (2023)

Gastric cancer peritoneal metastasis related signature predicts prognosis and sensitivity to immunotherapy in gastric cancer
por: Sun, YuQin, et al.
Publicado: (2023)

Identification of a polycomb group-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Liu, Lei, et al.
Publicado: (2023)

Comprehensive multi-omics analysis reveals m7G-related signature for evaluating prognosis and immunotherapy efficacy in osteosarcoma
por: Zhang, Yiming, et al.
Publicado: (2023)

The Comprehensive Analysis Identified an Autophagy Signature for the Prognosis and the Immunotherapy Efficiency Prediction in Lung Adenocarcinoma
por: Li, Xizhe, et al.
Publicado: (2022)

A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer
por: Zhang, Jinbao, et al.
Publicado: (2022)

Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma
por: Jiang, Silin, et al.
Publicado: (2023)

Immune‐related signature predicts the prognosis and immunotherapy benefit in bladder cancer
por: Wang, Yejinpeng, et al.
Publicado: (2020)

Landscape of prognosis and immunotherapy responsiveness under tumor glycosylation-related lncRNA patterns in breast cancer
por: Lv, Wenchang, et al.
Publicado: (2022)

The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit
por: Hou, Yue, et al.
Publicado: (2023)

Identification of a Signature for Predicting Prognosis and Immunotherapy Response in Patients with Glioma
por: Zong, Wei-Feng, et al.
Publicado: (2022)

A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer
por: Zhuang, Lingling, et al.
Publicado: (2023)

Construction of a tumor immune infiltration macrophage signature for predicting prognosis and immunotherapy response in liver cancer
por: Huang, Anmin, et al.
Publicado: (2022)

Identification of NAD(+) Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
por: Lin, Liang, et al.
Publicado: (2022)

Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer
por: Ding, Jinye, et al.
Publicado: (2023)

Construction of an Immunophenoscore-Related Signature for Evaluating Prognosis and Immunotherapy Sensitivity in Ovarian Cancer
por: Jiang, Haonan, et al.
Publicado: (2023)

Comprehensive pathway-related genes signature for prognosis and recurrence of ovarian cancer
por: Zhao, Xinnan, et al.
Publicado: (2020)

Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
por: Zhao, Xiashuang, et al.
Publicado: (2023)

Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy
por: Zhang, Si-yuan, et al.
Publicado: (2021)

Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer
por: Hui, Pengyu, et al.
Publicado: (2023)

Identification of an Aging-Related Gene Signature in Predicting Prognosis and Indicating Tumor Immune Microenvironment in Breast Cancer
por: Lv, Wenchang, et al.
Publicado: (2021)

An integrated lncRNA, microRNA and mRNA signature to improve prognosis prediction of colorectal cancer
por: Xiong, Yongfu, et al.
Publicado: (2017)

Comprehensive analyses of a tumor-infiltrating lymphocytes-related gene signature regarding the prognosis and immunologic features for immunotherapy in bladder cancer on the basis of WGCNA
por: He, Zexi, et al.
Publicado: (2022)

Prognosis and Immunotherapy Significances of a Cancer-Associated Fibroblasts-Related Gene Signature in Gliomas
por: Chen, Zhimin, et al.
Publicado: (2021)

Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer
por: Cao, Kui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_k5bvskrjg1sd72g6e3i7ptndcn